Thorsten Wiech Selected Research

Thorsten Wiech Research Topics

Disease

12	Membranous Glomerulonephritis (Membranous Nephropathy) 10/2021 - 07/2014
11	Glomerulonephritis 01/2022 - 11/2016
11	Proteinuria 01/2021 - 04/2010
9	Neoplasms (Cancer) 01/2020 - 03/2005
8	Kidney Diseases (Kidney Disease) 01/2022 - 01/2017
8	Inflammation (Inflammations) 11/2021 - 09/2015
4	Autoimmune Diseases (Autoimmune Disease) 10/2021 - 01/2016
4	Infections 01/2021 - 09/2015
4	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2020 - 11/2014
4	Fibrosis (Cirrhosis) 01/2020 - 09/2011
3	Thrombotic Microangiopathies 08/2021 - 01/2019
3	IGA Glomerulonephritis (IGA Nephropathy) 08/2021 - 01/2019
3	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 07/2010
3	Renal Insufficiency (Renal Failure) 01/2020 - 09/2011
3	Atypical Hemolytic Uremic Syndrome 01/2020 - 11/2011
3	Nephritis 01/2018 - 01/2017
3	Paraganglioma (Paragangliomas) 09/2012 - 01/2012
3	Adenocarcinoma 01/2011 - 08/2007
2	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2022 - 01/2019
2	Disease Progression 12/2021 - 01/2021
2	Necrosis 11/2021 - 01/2020
2	Lupus Nephritis 08/2021 - 01/2019
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2020 - 11/2014
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 12/2018
2	Vasculitis (Vasculitides) 01/2019 - 01/2018
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 06/2011
2	Hypertrophy 01/2019 - 07/2014
2	Hypertension (High Blood Pressure) 12/2018 - 08/2014
2	Wounds and Injuries (Trauma) 11/2014 - 07/2010
2	von Hippel-Lindau Disease (von Hippel Lindau Disease) 09/2012 - 06/2012
2	Pheochromocytoma 09/2012 - 06/2012
1	Ciliopathies 01/2022
1	Albuminuria 01/2022
1	Hyperglycemia 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Thrombosis (Thrombus) 11/2021
1	Heart Failure 10/2021
1	COVID-19 10/2021
1	Fever (Fevers) 01/2021
1	Hemoptysis 01/2021
1	Hypercholesterolemia 01/2020
1	Chronic Renal Insufficiency 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Segmental glomerulosclerosis 01/2020
1	Liver Diseases (Liver Disease) 01/2019
1	Immunoglobulin G4-Related Disease 01/2019
1	Cholestasis 01/2019

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2008
11	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 08/2021 - 01/2015
8	Complement System Proteins (Complement)IBA 12/2021 - 09/2015
5	AntigensIBA 01/2022 - 01/2017
5	ThrombospondinsIBA 10/2021 - 01/2017
5	Phospholipase A2 ReceptorsIBA 10/2021 - 01/2017
5	CreatinineIBA 01/2021 - 11/2010
5	DNA (Deoxyribonucleic Acid)IBA 07/2012 - 11/2008
4	Complement Factor H (Factor H)IBA 11/2021 - 01/2018
4	AntibodiesIBA 01/2021 - 01/2017
3	ParaffinIBA 01/2011 - 03/2005
3	Formaldehyde (Formol)FDA Link 01/2011 - 03/2005
2	nephrinIBA 01/2022 - 01/2017
2	Peptides (Polypeptides)IBA 12/2021 - 10/2021
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2017
2	AutoantigensIBA 01/2020 - 01/2018
2	Chemokine ReceptorsIBA 12/2018 - 01/2016
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018 - 11/2014
2	Biomarkers (Surrogate Marker)IBA 09/2015 - 11/2014
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 09/2012 - 06/2012
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	ApolipoproteinsIBA 11/2021
1	C-Reactive ProteinIBA 11/2021
1	LipidsIBA 11/2021
1	factor H-related protein 1IBA 11/2021
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 11/2021
1	NeopterinIBA 11/2021
1	CollagenIBA 10/2021
1	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 10/2021
1	AutoantibodiesIBA 10/2021
1	Natural Killer Cell ReceptorsIBA 01/2021
1	LigandsIBA 01/2021
1	Unithiol (DMPS)IBA 01/2021
1	Thioctic Acid (Lipoic Acid)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	NivolumabIBA 01/2020
1	AnnexinsIBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	CytokinesIBA 01/2020
1	Interleukin-9 (Interleukin 9)IBA 01/2020
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2020
1	Adenine FDA LinkGeneric 01/2020
1	IpilimumabIBA 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2019
1	BilirubinIBA 01/2019
1	CholesterolIBA 01/2019

Therapy/Procedure

6	Therapeutics 01/2020 - 03/2010
1	Self Medication 01/2021